Edit Module

Novartis Launches 3-Day Feline NSAID


Novartis Animal Health launched Onsior (robenacoxib) tablets, a three-day non-steroidal anti-inflammatory drug for postoperative cats, the Greensboro, N.C., company reported today.

The drug is indicated for the control of postoperative pain and inflammation associated with orthopedic surgery, ovariohysterectomy and castration. It is the first multidose oral NSAID to be approved for cats, Novartis reported.

The drug’s short blood half-life causes the active ingredient to be quickly eliminated from the blood while persisting longer at the site of inflamed tissue, allowing for once-a-day administration for up to three days, the company reported.

Side effects observed during a clinical field trial and six-month safety study included surgical site bleeding, infected surgery sites, lethargy, vomiting and inappetence.

The drug is indicated for cats weighing 5.5 pounds or heavier and at least 6 months old for a maximum of three days. The drug should not be used in cats that have a hypersensitivity to robenacoxib or known intolerance to NSAIDs and should not be administered in conjunction with any other oral or injectable NSAID or corticosteroid, according to Novartis.


Edit Module
Edit ModuleShow Tags

Archive »Read More

New Treatment Could Prevent Uterine Disease in Cows

University of Florida researchers say that a new biological treatment could prevent dairy cattle from getting uterine diseases.

Michigan Revamps Vet Curriculum with Hopes to Reduce Student Debt

In an effort to reduce student debt, Michigan State University’s College of Veterinary Medicine plans to implement a new curriculum by fall semester 2018.

Cat-Killing Vet Has License Suspended

The lawyer for Kristen Lindsey, DVM, the veterinarian who killed a cat with a bow-and-arrow, vowed to appeal the decision.

Add your comment:
Edit Module
Edit Module
Edit ModuleEdit ModuleShow Tags Edit Module
Edit Module Edit Module
Edit ModuleShow Tags


Show More...
Edit Module
Edit Module